Previous 10 | Next 10 |
home / stock / ajiny / ajiny news
Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-06-30 Humanigen Inc. (HGEN) is expected to report for Q2 2023 Ever-Glory International Group Inc. (EVKG) is expected to report for quarter end 2023-06-30 SunCar Technology Group Inc. (SDA) is expected to ...
Regenicin Inc (RGIN) is expected to report for quarter end 2023-06-30 Grasim Industries Ltd. ADR (GRSXY) is expected to report for quarter end 2023-06-30 Mitsubishi Heavy Industries Ltd. (MHVYF) is expected to report for Q1 2024 Japan Tobacco Inc. ADR (JAPAY) is expected to report $0....
World Copper (WCUFF) is expected to report $-0.01 for Q2 2023 GlassBridge Enterprises Inc (GLAE) is expected to report for quarter end 2023-06-30 Paladin Energy Ltd (PALAF) is expected to report for Q4 2023 Andritz AG ADR (ADRZY) is expected to report for Q2 2023 Cincinnati Bancor...
Anebulo Pharmaceuticals Inc. (ANEB) is expected to report for Q4 2023 Minera IRL Ltd ADR (MRLLY) is expected to report for Q3 2023 OpenLocker Holdings Inc (OLKR) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-0.43 for Q2 2024 Sompo Holdings I...
Greenrose Holding Company Inc The Com (GNRS) is expected to report for quarter end 2023-06-30 Bridgford Foods Corporation (BRID) is expected to report for Q1 2024 Compagnie financiere Richemont SA ADR (CFRUY) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is e...
Ajinomoto Co. Inc ADR (AJINY) is expected to report for quarter end 2023-06-30
2023-06-29 05:21:41 ET Artificial sweetener aspartame, commonly used in diet sodas and low-calorie packaged food, is expected to be declared a possible carcinogen next month by the World Health Organization's cancer research arm, Reuters reported citing unnamed sources. The Interna...
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase PR Newswire TOKYO , Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufac...
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer PR Newswire TOKYO , Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreeme...
The shares in PLAID have corrected over 80% YTD, but fundamentals remain negative. The company's CX SaaS metrics point to low customer success, and management has highlighted its competitive weakness versus peers in terms of price and value. Despite the shares trading on Price to ...
News, Short Squeeze, Breakout and More Instantly...
Ajinomoto Co. Inc. ADR Company Name:
AJINY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium PR Newswire Leveraging Advanced Manufacturing and Strict Quality Control for Superior Performance in Cellular Medicine TOKYO , March 26 , 2024 /PRNewswire/ -- Today, Ajinomoto Co., Inc. (...
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...